The goals of acromegaly therapy, such as neurosurgical treatment and somatostatin analogues are mainly to normalise GH and IGF-1 levels, lower symptoms, reduce the risk of developing comorbidities, and prolong survival13,14. Here, GH1 is linked to acromegaly.